News & Analysis
/
Article

Urokinase plasminogen activator detector helps monitor cancer

FEB 07, 2020
A quick and flexible urokinase plasminogen activator detector leads to inexpensive detection and monitoring of cancer.
Urokinase plasminogen activator detector helps monitor cancer internal name

Urokinase plasminogen activator detector helps monitor cancer lead image

High levels of urokinase plasminogen activator (uPA) can indicate cancer metastasis. This protein converts plasminogen to an enzyme called plasmin, which causes the breakdown proteins in blood and the extracellular matrix. Degraded proteins in the extracellular matrix are a component of cancer movement and proliferation, indicating that through successful detection of uPA, scientists can monitor and diagnose cancer.

Sharma et al. developed a uPA sensing technique based on a paper-based, graphene-gold nanoparticle platform that can detect uPA with high specificity and high sensitivity. The device is physically flexible and inexpensive.

On the graphene and gold nanoparticle-based sensing platform, cadmium selenide quantum dots were coated with uPA antibodies. When the quantum dots are within ∼20 nanometers from graphene, the graphene in the platform reduces the fluorescence of the quantum dots.

“When we add any biological fluid that may contain uPA, uPA binds to the antibody on the quantum dot. This causes a ‘lift’ of the quantum dot, taking it farther away from graphene, thus reducing the quenching [of the fluorescence],” said author Bipin Sharma. “This means that the addition of uPA disrupts quenching, thereby increasing the quantum dot fluorescence.”

The authors intend on further miniaturizing the device, which they believe can be integrated into a hand-held electronic device. The devices low sample volume would allow easy and accurate estimation of uPA levels in blood.

“In low- and middle-income countries, a majority of the population don’t have access to state-of-the-art healthcare facilities, due to location and inaccessibility. With hand-held, point-of-care sensors, the people will have access to a diagnostic tool for them to detect diseases without having to travel very far or spend too much,” said author Ramakrishna Podila

Source: “Rapid detection of urokinase plasminogen activator using flexible paper-based graphene-gold platform,” by Bipin Sharma, Prakash Parajuli, and Ramakrishna Podila, Biointerphases (2020). The article can be accessed at https://doi.org/10.1116/1.5128889 .

Related Topics
More Science
/
Article
In the treatment of inflammatory bowel disease, synthetic mucus gels can be used to deliver monoclonal antibodies without inducing broad immunosuppression.
APS
/
Article
In an interview, the 2026 APS president outlines his career, his goals for the year, and where he finds optimism in challenging times.
/
Article
Examining role of thermal resistance in promising new solid-state energy generation.
/
Article
Findings point to improved performance of bifacial solar panels that are flat, compared to curved, in terms of power generation.